We found that T-oligo treatment inhibits HIF-1α activity and ANG-1 and ANG-2 expression in melanoma cell line and decreases VEGF synthesis secretion in these cells, strongly suggesting that T-oligo-mediated effects on tumor angiogenesis are transcriptional and ultimately affect several angiogenic molecules. The gene discussed is VEGFA; the disease is neoplasm.